FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897574443> ?p ?o ?g. }

• W2897574443 endingPage "e021488" @default.
• W2897574443 startingPage "e021488" @default.
• W2897574443 abstract "Introduction Ventilator-associated pneumonia (VAP) is the first cause of healthcare-associated infections in intensive care units (ICUs) and brain injury is one of the main risk factors for early-onset VAP. Antibiotic prophylaxis has been reported to decrease their occurrence in brain-injured patients, but a lack of controlled randomised trials and the risk of induction of bacterial resistance explain the low level of recommendations. The goal of this study is to determine whether a single dose of ceftriaxone within the 12 hours postintubation after severe brain injury can decrease the risk of early-onset VAP. Methods and analysis The PROPHY-VAP is a French multicentre, randomised, double-blind, placebo-controlled, clinical trial. Adult brain-injured patients (n=320) with a Glasgow Coma Scale ≤12, requiring mechanical ventilation for more than 48 hours, are randomised to receive either a single dose of ceftriaxone 2 g or a placebo within the 12 hours after tracheal intubation. The primary endpoint is the proportion of patients developing VAP from the 2nd to the 7th day after mechanical ventilation. Secondary endpoints include the proportion of patients developing late VAP (>7 days after tracheal intubation), the number of ventilator-free days, VAP-free days and antibiotic-free days, length of stay in the ICU, proportion of patients with ventilator-associated events and mortality during their ICU stay. Ethics and dissemination The initial research project was approved by the Institutional Review Board of OUEST III (France) on 20 October 2014 (registration No 2014-001668-36) and carried out according to the principles of the Declaration of Helsinki and the Clinical Trials Directive 2001/20/EC of the European Parliament relating to the Good Clinical Practice guidelines. The results of this study will be presented in national and international meetings and published in an international peer-reviewed journal. Trial registration number NCT02265406 ; Pre-results." @default.
• W2897574443 created "2018-10-26" @default.
• W2897574443 creator A5005395816 @default.
• W2897574443 creator A5006873154 @default.
• W2897574443 creator A5009705287 @default.
• W2897574443 creator A5017719189 @default.
• W2897574443 creator A5030186912 @default.
• W2897574443 creator A5030969793 @default.
• W2897574443 creator A5032293357 @default.
• W2897574443 creator A5032625524 @default.
• W2897574443 creator A5042465117 @default.
• W2897574443 creator A5060655080 @default.
• W2897574443 creator A5070261387 @default.
• W2897574443 creator A5071434798 @default.
• W2897574443 creator A5082532956 @default.
• W2897574443 creator A5084335269 @default.
• W2897574443 date "2018-10-01" @default.
• W2897574443 modified "2023-10-14" @default.
• W2897574443 title "Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial" @default.
• W2897574443 cites W1709269893 @default.
• W2897574443 cites W1964644003 @default.
• W2897574443 cites W1969907584 @default.
• W2897574443 cites W1977100250 @default.
• W2897574443 cites W1977782117 @default.
• W2897574443 cites W1978956552 @default.
• W2897574443 cites W1980980484 @default.
• W2897574443 cites W1993489761 @default.
• W2897574443 cites W2020783110 @default.
• W2897574443 cites W2022235858 @default.
• W2897574443 cites W2032541700 @default.
• W2897574443 cites W2036028217 @default.
• W2897574443 cites W2059579910 @default.
• W2897574443 cites W2061393918 @default.
• W2897574443 cites W2069969451 @default.
• W2897574443 cites W2093134387 @default.
• W2897574443 cites W2095665758 @default.
• W2897574443 cites W2103315560 @default.
• W2897574443 cites W2105011964 @default.
• W2897574443 cites W2108646122 @default.
• W2897574443 cites W2111308633 @default.
• W2897574443 cites W2163264981 @default.
• W2897574443 cites W2165558884 @default.
• W2897574443 cites W2229811649 @default.
• W2897574443 cites W2411436049 @default.
• W2897574443 cites W2473016454 @default.
• W2897574443 cites W4211194064 @default.
• W2897574443 cites W4230039603 @default.
• W2897574443 cites W52916385 @default.
• W2897574443 doi "https://doi.org/10.1136/bmjopen-2018-021488" @default.
• W2897574443 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6196869" @default.
• W2897574443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30341115" @default.
• W2897574443 hasPublicationYear "2018" @default.
• W2897574443 type Work @default.
• W2897574443 sameAs 2897574443 @default.
• W2897574443 citedByCount "10" @default.
• W2897574443 countsByYear W28975744432019 @default.
• W2897574443 countsByYear W28975744432020 @default.
• W2897574443 countsByYear W28975744432021 @default.
• W2897574443 countsByYear W28975744432022 @default.
• W2897574443 countsByYear W28975744432023 @default.
• W2897574443 crossrefType "journal-article" @default.
• W2897574443 hasAuthorship W2897574443A5005395816 @default.
• W2897574443 hasAuthorship W2897574443A5006873154 @default.
• W2897574443 hasAuthorship W2897574443A5009705287 @default.
• W2897574443 hasAuthorship W2897574443A5017719189 @default.
• W2897574443 hasAuthorship W2897574443A5030186912 @default.
• W2897574443 hasAuthorship W2897574443A5030969793 @default.
• W2897574443 hasAuthorship W2897574443A5032293357 @default.
• W2897574443 hasAuthorship W2897574443A5032625524 @default.
• W2897574443 hasAuthorship W2897574443A5042465117 @default.
• W2897574443 hasAuthorship W2897574443A5060655080 @default.
• W2897574443 hasAuthorship W2897574443A5070261387 @default.
• W2897574443 hasAuthorship W2897574443A5071434798 @default.
• W2897574443 hasAuthorship W2897574443A5082532956 @default.
• W2897574443 hasAuthorship W2897574443A5084335269 @default.
• W2897574443 hasBestOaLocation W28975744431 @default.
• W2897574443 hasConcept C126322002 @default.
• W2897574443 hasConcept C141071460 @default.
• W2897574443 hasConcept C142724271 @default.
• W2897574443 hasConcept C168563851 @default.
• W2897574443 hasConcept C17624336 @default.
• W2897574443 hasConcept C177713679 @default.
• W2897574443 hasConcept C203092338 @default.
• W2897574443 hasConcept C204787440 @default.
• W2897574443 hasConcept C27081682 @default.
• W2897574443 hasConcept C2776376669 @default.
• W2897574443 hasConcept C2776520383 @default.
• W2897574443 hasConcept C2777080012 @default.
• W2897574443 hasConcept C2777184939 @default.
• W2897574443 hasConcept C2777914695 @default.
• W2897574443 hasConcept C2778716859 @default.
• W2897574443 hasConcept C2987404301 @default.
• W2897574443 hasConcept C42219234 @default.
• W2897574443 hasConcept C501593827 @default.
• W2897574443 hasConcept C535046627 @default.
• W2897574443 hasConcept C71924100 @default.
• W2897574443 hasConcept C86803240 @default.
• W2897574443 hasConcept C89423630 @default.

• next